926 Intralesional vaccinia virus-interleukin 2 (VV-IL2) gene therapy in malignant mesothelioma (MM)

Autor:	D. Smith, G. Harnett, B. W. S. Robinson, M. Epton, Arthur W. Musk, Sutapa Mukherjee, T. Haenel, I. Ramshaw, Richard A. Lake, P. Phillips, S. Morey, J.A. Davidson, P. Drury
Rok vydání:	1997
Předmět:	Pulmonary and Respiratory Medicine Interleukin 2 Cancer Research business.industry Genetic enhancement medicine.disease Virology Virus chemistry.chemical_compound Oncology chemistry Medicine Mesothelioma Vaccinia business medicine.drug
Zdroj:	Lung Cancer. 18:236
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(97)80301-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::442abbbec55c02493697e1e2d4deaab6 https://doi.org/10.1016/s0169-5002(97)80301-7 Zobrazit plný text záznamu Full Text from ScienceDirect